Table 4.
Echo-Doppler measurement in anti-CCP positive and anti-CCP negative RA patients.
| Echo-Doppler parameter | Anti-CCP positive RA (n = 40) | Anti-CCP negative RA (n = 40) | P value |
|---|---|---|---|
| LAD (mm) | 27.55 ± 6.44 | 28.93 ± 4.01 | 0.255 |
| Aortic root diameter (mm) | 23.05 ± 5.4 | 24.95 ± 4.18 | 0.082 |
| Cusp opening (mm) | 15.38 ± 2.66 | 17.30 ± 3.34 | 0.006* |
| RVID (mm) | 15.13 ± 3.41 | 15.00 ± 2.55 | 0.85 |
| IVSD (mm) | 10.05 ± 2.10 | 8.73 ± 1.22 | 0.001* |
| LVPW (mm) | 10.05 ± 1.60 | 9.5 ± 0.93 | 0.064 |
| LVIDD (mm) | 41.60 ± 3.59 | 40.83 ± 3.38 | 0.323 |
| LVIDS (mm) | 26.25 ± 4.83 | 24.78 ± 2.53 | 0.091 |
| LVEF % | 64.55 ± 12.01 | 69.73 ± 3.22 | 0.01* |
| MV E velocity (cm/s) | 84.95 ± 16.88 | 96.68 ± 15.68 | 0.002* |
| MV A velocity (cm/s) | 67.25 ± 14.14 | 62.63 ± 11.07 | 0.107 |
| E/A ratio | 1.33 ± 0.40 | 1.57 ± 0.29 | 0.002* |
| E/A ratio <1 | 10 (25%) | 3 (7.5%) | 0.034* |
| MV Dec Time (ms) | 211.3 ± 29.51 | 197.13 ± 24.72 | 0.022* |
| LVM (g) | 1.39 ± 4.45 | 1.16 ± 2.02 | 0.003* |
| LVMI (g/m2) | 9.51 ± 3.01 | 7.86 ± 1.20 | 0.002* |
| IVRT (ms) | 83.93 ± 18.25 | 74.25 ± 17.45 | 0.018* |
| Diastolic dysfunction | 10 (25%) | 3 (7.5%) | 0.034* |
| Pericardial effusion | 4 (10%) | 1 (2.5%) | 0.166 |
| Pericardial thickening | 5 (12.5%) | 0 (0%) | 0.021* |
| MR | 6 (15%) | 1 (2.5%) | 0.048* |
*P value statistically significant. LAD – Left atrial diameter; RVID – Right ventricular internal diameter; IVSD – Interventricular septal diameter; LVPW – Left ventricular posterior wall; LVIDD – Left ventricular internal diameter in diastole; LVIDS – Left ventricular internal diameter in systole; LVEF % – Left ventricular ejection fraction; MV E velocity – Mitral valve E velocity; MV A velocity – Mitral valve A velocity; MV Dec Time – Mitral valve deceleration time; LVM – Left ventricular mass; LVMI – Left ventricular mass indexed to body surface area; IVRT – Isovolumetric relaxation time; MR – Mitral regurgitation.